| Symbol |
Name |
Standardized Value |
|
FH
|
fumarate hydratase
|
3.82
|
|
COL4A6
|
collagen, type IV, alpha 6
|
2.984
|
|
COL4A5
|
collagen, type IV, alpha 5
|
2.806
|
|
FLCN
|
folliculin
|
2.711
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
2.657
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
2.555
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
2.448
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
2.444
|
|
MED12
|
mediator complex subunit 12
|
2.414
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
2.268
|
|
ELOC
|
elongin C
|
2.246
|
|
SDHAF2
|
succinate dehydrogenase complex assembly factor 2
|
2.207
|
|
EPAS1
|
endothelial PAS domain protein 1
|
2.199
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
2.198
|
|
SETD2
|
SET domain containing 2
|
2.184
|
|
PBRM1
|
polybromo 1
|
2.175
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
2.158
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
2.153
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
2.125
|
|
TFEB
|
transcription factor EB
|
2.12
|
|
CALD1
|
caldesmon 1
|
2.107
|
|
COL4A4
|
collagen, type IV, alpha 4
|
2.098
|
|
TSC2
|
tuberous sclerosis 2
|
2.043
|
|
HMGA2
|
high mobility group AT-hook 2
|
2.006
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
2.005
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
2.004
|
|
LDHA
|
lactate dehydrogenase A
|
1.993
|
|
MITF
|
microphthalmia-associated transcription factor
|
1.967
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
1.959
|
|
ACO2
|
aconitase 2, mitochondrial
|
1.954
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
1.922
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
1.918
|
|
ARMC5
|
armadillo repeat containing 5
|
1.91
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
1.901
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
1.896
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.887
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
1.885
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
1.876
|
|
PTEN
|
phosphatase and tensin homolog
|
1.865
|
|
TP53
|
tumor protein p53
|
1.855
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
1.844
|
|
CA9
|
carbonic anhydrase IX
|
1.787
|
|
FNIP1
|
folliculin interacting protein 1
|
1.766
|
|
TMEM127
|
transmembrane protein 127
|
1.764
|
|
PDE11A
|
phosphodiesterase 11A
|
1.761
|
|
MME
|
membrane metallo-endopeptidase
|
1.754
|
|
MDH2
|
malate dehydrogenase 2, NAD (mitochondrial)
|
1.753
|
|
PGR
|
progesterone receptor
|
1.752
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.747
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
1.742
|
|
EIF5B
|
eukaryotic translation initiation factor 5B
|
1.739
|
|
MEN1
|
multiple endocrine neoplasia I
|
1.731
|
|
ASL
|
argininosuccinate lyase
|
1.714
|
|
CUL3
|
cullin 3
|
1.709
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
1.709
|
|
NF2
|
neurofibromin 2 (merlin)
|
1.7
|
|
PDE8B
|
phosphodiesterase 8B
|
1.698
|
|
FNIP2
|
folliculin interacting protein 2
|
1.695
|
|
KDM5C
|
lysine (K)-specific demethylase 5C
|
1.692
|
|
ACO1
|
aconitase 1, soluble
|
1.686
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
1.683
|
|
L2HGDH
|
L-2-hydroxyglutarate dehydrogenase
|
1.678
|
|
KRT7
|
keratin 7, type II
|
1.677
|
|
KDM4B
|
lysine (K)-specific demethylase 4B
|
1.666
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
1.663
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.651
|
|
PAX8
|
paired box 8
|
1.645
|
|
ESR1
|
estrogen receptor 1
|
1.627
|
|
ACLY
|
ATP citrate lyase
|
1.619
|
|
PKM
|
pyruvate kinase, muscle
|
1.602
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.601
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
1.6
|
|
CD34
|
CD34 molecule
|
1.598
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.597
|
|
TSC1
|
tuberous sclerosis 1
|
1.564
|
|
BET1L
|
Bet1 golgi vesicular membrane trafficking protein-like
|
1.56
|
|
PLD5
|
phospholipase D family, member 5
|
1.56
|
|
CUL2
|
cullin 2
|
1.559
|
|
ELOB
|
elongin B
|
1.558
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.554
|
|
CS
|
citrate synthase
|
1.539
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
1.527
|
|
D2HGDH
|
D-2-hydroxyglutarate dehydrogenase
|
1.518
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
1.516
|
|
PGD
|
phosphogluconate dehydrogenase
|
1.512
|
|
ESPN
|
espin
|
1.512
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
1.509
|
|
GLS
|
glutaminase
|
1.509
|
|
TGFA
|
transforming growth factor, alpha
|
1.507
|
|
SLC25A11
|
solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11
|
1.5
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.481
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.478
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.476
|
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5
|
1.473
|
|
RET
|
ret proto-oncogene
|
1.465
|
|
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1
|
1.459
|
|
STK11
|
serine/threonine kinase 11
|
1.455
|
|
RGS7
|
regulator of G-protein signaling 7
|
1.453
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
1.443
|
|
KDM2B
|
lysine (K)-specific demethylase 2B
|
1.443
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
1.439
|
|
NF1
|
neurofibromin 1
|
1.439
|
|
BRCA1
|
breast cancer 1, early onset
|
1.418
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
1.407
|
|
SLC16A4
|
solute carrier family 16, member 4
|
1.401
|
|
EGFR
|
epidermal growth factor receptor
|
1.392
|
|
IDH3B
|
isocitrate dehydrogenase 3 (NAD+) beta
|
1.39
|
|
CDH16
|
cadherin 16, KSP-cadherin
|
1.389
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
1.381
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
1.38
|
|
SLC16A3
|
solute carrier family 16 (monocarboxylate transporter), member 3
|
1.38
|
|
BRCA2
|
breast cancer 2, early onset
|
1.38
|
|
MSH2
|
mutS homolog 2
|
1.379
|
|
ASS1
|
argininosuccinate synthase 1
|
1.371
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
1.366
|
|
CDC73
|
cell division cycle 73
|
1.36
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
1.36
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.359
|
|
SDHAF1
|
succinate dehydrogenase complex assembly factor 1
|
1.357
|
|
PC
|
pyruvate carboxylase
|
1.357
|
|
MSH6
|
mutS homolog 6
|
1.355
|
|
ATM
|
ATM serine/threonine kinase
|
1.353
|
|
CD274
|
CD274 molecule
|
1.343
|
|
SUCNR1
|
succinate receptor 1
|
1.343
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
1.34
|
|
CHEK2
|
checkpoint kinase 2
|
1.34
|
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase
|
1.339
|
|
IREB2
|
iron-responsive element binding protein 2
|
1.337
|
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2
|
1.331
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
1.324
|
|
CTSK
|
cathepsin K
|
1.32
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.32
|
|
H3-3B
|
H3.3 histone B
|
1.312
|
|
ACSS1
|
acyl-CoA synthetase short-chain family member 1
|
1.309
|
|
TERT
|
telomerase reverse transcriptase
|
1.309
|
|
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide)
|
1.308
|
|
MLH1
|
mutL homolog 1
|
1.3
|
|
VHLL
|
von Hippel-Lindau tumor suppressor-like
|
1.295
|
|
PFKM
|
phosphofructokinase, muscle
|
1.292
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.288
|
|
ADSL
|
adenylosuccinate lyase
|
1.288
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
1.287
|
|
WDR64
|
WD repeat domain 64
|
1.282
|
|
HMOX1
|
heme oxygenase 1
|
1.281
|
|
WT1
|
Wilms tumor 1
|
1.277
|
|
COL4A2
|
collagen, type IV, alpha 2
|
1.257
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
1.248
|
|
FASN
|
fatty acid synthase
|
1.246
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
1.244
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
1.241
|
|
IRS4
|
insulin receptor substrate 4
|
1.239
|
|
H3-4
|
H3.4 histone, cluster member
|
1.235
|
|
H3C13
|
H3 clustered histone 13
|
1.215
|
|
H3-5
|
H3.5 histone
|
1.215
|
|
H3C12
|
H3 clustered histone 12
|
1.213
|
|
KRT20
|
keratin 20, type I
|
1.211
|
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
1.206
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
1.204
|
|
RAD51B
|
RAD51 paralog B
|
1.203
|
|
TNRC6B
|
trinucleotide repeat containing 6B
|
1.203
|
|
SLC49A4
|
solute carrier family 49 member 4
|
1.2
|
|
TIGAR
|
TP53 induced glycolysis regulatory phosphatase
|
1.197
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
1.197
|
|
CCND1
|
cyclin D1
|
1.196
|
|
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II
|
1.19
|
|
P4HA1
|
prolyl 4-hydroxylase, alpha polypeptide I
|
1.19
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.189
|
|
GPX4
|
glutathione peroxidase 4
|
1.187
|
|
TALDO1
|
transaldolase 1
|
1.186
|
|
KDR
|
kinase insert domain receptor
|
1.183
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
1.181
|
|
FBP1
|
fructose-1,6-bisphosphatase 1
|
1.18
|
|
PDP2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2
|
1.174
|
|
KIF1B
|
kinesin family member 1B
|
1.172
|
|
TFAM
|
transcription factor A, mitochondrial
|
1.17
|
|
CSDE1
|
cold shock domain containing E1, RNA-binding
|
1.166
|
|
ME1
|
malic enzyme 1, NADP(+)-dependent, cytosolic
|
1.166
|
|
HIF3A
|
hypoxia inducible factor 3, alpha subunit
|
1.162
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
1.162
|
|
HOOK2
|
hook microtubule-tethering protein 2
|
1.155
|
|
COL4A1
|
collagen, type IV, alpha 1
|
1.152
|
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2
|
1.15
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
1.146
|
|
HK2
|
hexokinase 2
|
1.146
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
1.142
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.139
|
|
NEIL2
|
nei endonuclease VIII-like 2 (E. coli)
|
1.139
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
1.133
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.131
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
1.13
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
1.129
|
|
H2AZ1
|
H2A.Z variant histone 1
|
1.122
|
|
AXL
|
AXL receptor tyrosine kinase
|
1.121
|
|
NFU1
|
NFU1 iron-sulfur cluster scaffold
|
1.115
|
|
SIRT3
|
sirtuin 3
|
1.112
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
1.111
|
|
PALB2
|
partner and localizer of BRCA2
|
1.109
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
1.108
|
|
GLRX2
|
glutaredoxin 2
|
1.107
|
|
EPO
|
erythropoietin
|
1.106
|
|
SIRT5
|
sirtuin 5
|
1.104
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.099
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
1.09
|
|
TKTL2
|
transketolase-like 2
|
1.089
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
1.087
|
|
MAX
|
MYC associated factor X
|
1.086
|
|
CALB2
|
calbindin 2
|
1.085
|
|
NONO
|
non-POU domain containing, octamer-binding
|
1.08
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.079
|
|
TKTL1
|
transketolase-like 1
|
1.076
|
|
VSTM2A
|
V-set and transmembrane domain containing 2A
|
1.075
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.074
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
1.064
|
|
STRN
|
striatin, calmodulin binding protein
|
1.063
|
|
TKT
|
transketolase
|
1.061
|
|
SIRT4
|
sirtuin 4
|
1.057
|
|
HHATL
|
hedgehog acyltransferase-like
|
1.057
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
1.056
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
1.055
|
|
CDK8
|
cyclin-dependent kinase 8
|
1.049
|
|
IDH3A
|
isocitrate dehydrogenase 3 (NAD+) alpha
|
1.048
|
|
TXN
|
thioredoxin
|
1.046
|
|
HOOK1
|
hook microtubule-tethering protein 1
|
1.045
|
|
FANCM
|
Fanconi anemia, complementation group M
|
1.045
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
1.042
|
|
HELLS
|
helicase, lymphoid-specific
|
1.04
|
|
CARMIL2
|
capping protein regulator and myosin 1 linker 2
|
1.04
|
|
NFE2
|
nuclear factor, erythroid 2
|
1.039
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.038
|
|
EXO1
|
exonuclease 1
|
1.037
|
|
CYCS
|
cytochrome c, somatic
|
1.037
|
|
GNAS
|
GNAS complex locus
|
1.037
|
|
CDK4
|
cyclin-dependent kinase 4
|
1.036
|
|
IFNA1
|
interferon, alpha 1
|
1.032
|
|
YEATS4
|
YEATS domain containing 4
|
1.03
|
|
PHGDH
|
phosphoglycerate dehydrogenase
|
1.029
|
|
IL2
|
interleukin 2
|
1.027
|
|
PAX2
|
paired box 2
|
1.027
|
|
MTHFD2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
|
1.023
|
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1
|
1.022
|
|
GRIPAP1
|
GRIP1 associated protein 1
|
1.021
|
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1
|
1.02
|
|
MUTYH
|
mutY homolog
|
1.019
|
|
SHMT2
|
serine hydroxymethyltransferase 2 (mitochondrial)
|
1.019
|
|
MITD1
|
MIT, microtubule interacting and transport, domain containing 1
|
1.015
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.013
|
|
RHEB
|
Ras homolog enriched in brain
|
1.013
|
|
GOT2
|
glutamic-oxaloacetic transaminase 2, mitochondrial
|
1.011
|
|
PDC
|
phosducin
|
1.01
|
|
GATA3
|
GATA binding protein 3
|
1.009
|
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
|
1.007
|
|
BARD1
|
BRCA1 associated RING domain 1
|
1.005
|
|
FTL
|
ferritin, light polypeptide
|
1.001
|
